Brind.

Gossamer Bio shares surged 139.9% on August 6, 2025, significantly outperforming the S&P 500's 7.6% gain.

1 report, 1 independent Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Gossamer Bio shares surged 139.9% on August 6, 2025, significantly outperforming the S&P 500's 7.6% gain.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksGossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates Gossamer Bio (GOSS) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compare